Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Beijing Pearl Biotechnology Limited Liability Company

Clinical trials sponsored by Beijing Pearl Biotechnology Limited Liability Company, explained in plain language.

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New drug targets genetic weakness in deadly brain tumor

Disease control Ongoing

This clinical trial tests a new drug called vebreltinib (PLB1001) in people with a recurrent form of glioblastoma that has a specific genetic change (ZM fusion gene). The study compares vebreltinib to standard chemotherapy to see if it helps people live longer. About 84 participa…

Phase: PHASE2, PHASE3 • Sponsor: Beijing Pearl Biotechnology Limited Liability Company • Aim: Disease control

Last updated Jun 27, 2026 08:13 UTC